Cybin Therapeutics, k'hamphani e ikemetseng ea therapeutic bioscience e morerong oa ho sibolla le ho nts'etsapele liprothokholo tsa kalafo tse thusoang ke psilocybin, e fane ka laesense ea PEX010 (25 mg) ho tsoa ho Filament hore e sebelisoe tekong. Teko e lebeletsoe ho qala ka Q3'22 'me e tla kenyelletsa batho ba nang le bothata bo boholo ba ho tepella maikutlo ba ntseng ba fuoa phekolo e khethehileng ea serotonin reuptake inhibitor (SSRI), e atisang ho sebelisoa ho phekola ho tepella maikutlong, hammoho le ba nang le SSRI-naive.
"Kamohelo ea Health Canada ke bopaki ba bonnete ba nyeoe ena hammoho le bokhoni ba Filament ba ho hlahisa le ho fana ka tumello ho batho ba etsang meriana ea boemo ba meriana," ho boletse Ofisiri e ka Sehloohong ea Filament, Benjamin Lightburn. "Phello ea phekolo ea psilocybin ho bakuli ba noang meriana ea setso ea SSRI e thibelang ho tepella maikutlo ke lipatlisiso tsa bohlokoa haholo 'me re thabela ho kenya letsoho phuputsong ena ea bohlokoa."
Josh Taylor, Mothehi oa Cybin Therapeutics, o itse: "Batho ba bangata ba Canada ba loantšanang le ho tepella maikutlo ba fumana phekolo ea SSRI, 'me ho fihlela joale, sena se bolela ho qheleloa ka thōko litekong tsa kliniki tsa psychedelic assisted psychotherapy (PAP). "Haeba ho ka bontšoa hore PAP e ka fuoa bakuli ba li-SSRI ka mokhoa o sireletsehileng le ka katleho, ba bangata ba tla rua molemo. Re nahana hore ona ke monyetla o motle oa ho bontša Health Canada hore Cybin Therapeutics e ka ntlafatsa sephetho sa bakuli le sehlopha sa rona le liprotheine tse ntlafetseng. "
Filament e boetse e fane ka tumello ea PEX010 (25 mg) ho CT bakeng sa liteko tse eketsehileng tsa kliniki tsa mohato oa 2, tse lebelletsoeng ho qala karolong ea bone ea 2022. Liteko ka bobeli li tla etelloa pele ke Dr. Reg Peters le Dave Phillips.
